Further studies with anti-NMD drugs in astrocytes treated with or without LPS or IL-1β could provide a proof of the possible role of NMD in eliminating the undetected mRNAs in 3-month-old AD mice and will be important for understanding its role in the regulation of MCT4 expression. The gene discussed is SLC16A3; the disease is Alzheimer disease.